Sonata Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,300
| Closed | -$289K | – | 127 |
|
|
2021
Q3 | $289K | Hold |
2,300
| – | – | 0.13% | 102 |
|
|
2021
Q2 | $311K | Hold |
2,300
| – | – | 0.14% | 103 |
|
|
2021
Q1 | $312K | Buy |
2,300
+200
| +10% | +$27.1K | 0.15% | 102 |
|
|
2020
Q4 | $296K | Hold |
2,100
| – | – | 0.15% | 100 |
|
|
2020
Q3 | $234K | Buy |
+2,100
| New | +$234K | 0.14% | 106 |
|
|
2017
Q4 | – | Sell |
-3,200
| Closed | -$277K | – | 103 |
|
|
2017
Q3 | $277K | Sell |
3,200
-250
| -7% | -$21.6K | 0.21% | 92 |
|
|
2017
Q2 | $266K | Hold |
3,450
| – | – | 0.2% | 91 |
|
|
2017
Q1 | $239K | Sell |
3,450
-750
| -18% | -$52K | 0.18% | 92 |
|
|
2016
Q4 | $249K | Sell |
4,200
-1,150
| -21% | -$68.2K | 0.19% | 90 |
|
|
2016
Q3 | $355K | Hold |
5,350
| – | – | 0.29% | 74 |
|
|
2016
Q2 | $289K | Hold |
5,350
| – | – | 0.25% | 80 |
|
|
2016
Q1 | $276K | Sell |
5,350
-2,450
| -31% | -$126K | 0.24% | 82 |
|
|
2015
Q4 | $548K | Buy |
7,800
+1,050
| +16% | +$73.8K | 0.48% | 51 |
|
|
2015
Q3 | $420K | Buy |
6,750
+2,250
| +50% | +$140K | 0.39% | 62 |
|
|
2015
Q2 | $378K | Buy |
+4,500
| New | +$378K | 0.32% | 73 |
|